Skip to content
Disclosery

Royalty Pharma Sub-Manager, LLC: ZBIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Royalty Pharma Sub-Manager, LLC on ZBIO, newest first. How the timeline and the estimate are built.

Royalty Pharma Sub-Manager, LLC held 2,388,150 ZBIO shares at 2026-06-30 per its 13F-HR/A filed 2026-08-21.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F/A 2,388,150 shares
    Change vs previous 13F 0 shares

    25.05% of the 13F portfolio, value $60,611,247.

    13F-HR/A 0002081668-26-000018 filed by Royalty Pharma Sub-Manager, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F/A 2,388,150 shares
    Change vs previous 13F +1,125,000 shares

    27.02% of the 13F portfolio, value $46,688,333.

    13F-HR/A 0002081668-26-000017 filed by Royalty Pharma Sub-Manager, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F/A 1,263,150 shares
    Change vs previous 13F not available

    26.77% of the 13F portfolio, value $45,864,977.

    13F-HR/A 0002081668-26-000015 filed by Royalty Pharma Sub-Manager, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).